One of the key participants in progression of Alzheimer’s disease (AD), amyloid peptide (Aβ) [3], is mostly bound to HSA (ca 89% of Aβ in blood plasma [4]). This evidence concerns the gene ALB and early-onset autosomal dominant Alzheimer disease.